Mifepristone has been used along with another drug — misoprostol — to end early pregnancies in about 7.5 million women since it was approved by the FDA in 2000.

About 57% of abortions in New Jersey were carried out using medication in 2023, according to the Kaiser Family Foundation.

Officials in New Jersey and other states petitioned the Trump administration on June 5 to waive current restrictions for a long-prescribed abortion pill that they argue block access to the drug, in the latest conflict over its use.

The petition from state Attorney General Matthew Platkin to the Food and Drug Administration comes three days after the agency's leader said he would oversee a safety review of the drug, mifepristone. The states are asking the FDA to use the safety review to lift the restrictions

See Full Page